Detailed instructions on the correct way to take Epclusa and daily dosage

Epclusa (Epclusa) is an oral direct antiviral drug (DAA), used to treat chronic hepatitis C (HCV) infection. Its main ingredients include sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir), which can inhibit HCV's NS5B polymerase and NS5A protein, thereby blocking virus replication and achieving the effect of clearing the virus. Gisanda is suitable for patients with all major genotypes of hepatitis C, including patients with mild to moderate liver function abnormalities.

In terms of dosage, the standard dosage of GIS is one tablet once a day. The tablet contains sofosbuvir 400mg and velpatasvir 100mg. Patients should take it orally at a fixed time every day to maintain stable blood concentration and improve efficacy. Jisandai can be taken with food or on an empty stomach, but it is recommended to take the entire tablet with water and not to crush, chew or take it separately to ensure drug stability and absorption.

The treatment cycle of Jisandai is generally 12 weeks. For most patients, there is no need to combine it with other drugs. A single drug can achieve a high virological response rate (SVR). During the treatment process, patients should strictly abide by the doctor's instructions and are not allowed to increase or decrease the dose or stop the drug early to avoid viral resistance or reduced efficacy. At the same time, regular monitoring of blood routine, liver function and viral load is very important for evaluating efficacy and safety.

In addition, Jisandai also has certain medication precautions for special groups of people. For patients with decompensated liver cirrhosis or patients with renal insufficiency, they need to be used under the guidance of a doctor; pregnant or lactating women should consult a professional doctor before use. Generally speaking, the correct taking method and fixed dosage are the keys to achieving the best efficacy of Jisandai. Patients should cooperate with regular follow-up during the entire course of treatment to ensure safe and effective elimination of hepatitis C virus.

Reference materials:https://www.drugs.com/